With 90% Efficacy, Novavax to Add Ammo to India's Vaccine Arsenal, Centre Looking to Fast-track Rollout
India is likely to proceed with the rollout of Novavax soon with Serum Institute as manufacturing partner on the basis of strong interim data. Overall, the efficacy of the vaccine was 90.4 per cent — that is, it showed the ability to bring down symptomatic Covid-19 cases by more than 90 per cent compared with […]